Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD

NCT: NCT03932773 · RECRUITING

NCT IDNCT03932773
StatusRECRUITING
Start Date2019-05-01
Completion2028-01-01
SponsorThe University of Texas at Dallas (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to examine the benefits of combining repetitive Transcranial Magnetic Stimulation (rTMS) coupled with Cognitive Processing Therapy (CPT) in treating combat-related Posttraumatic Stress Disorder (PTSD) symptoms. The study will also examine change in depression, psychosocial functioning, and neurophysiological (i.e., electroencephalography and magnetic resonance images) measures.

Frequently Asked Questions

What is Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD?

Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD is a clinical trial registered under NCT03932773. Current status: RECRUITING.

What is the status of NCT03932773?

The current status of NCT03932773 (Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD) is: RECRUITING.

When did Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD start?

Multi-site Confirmatory Efficacy Treatment Trial of Combat-related PTSD started on 2019-05-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.